The Global Biologic Injectors Market is poised for significant expansion by 2031, driven by rising prevalence of chronic diseases, advancements in biologic therapeutics, and increasing adoption of patient‑centric delivery systems. Biologic injectors—critical devices for administering complex biologic drugs such as monoclonal antibodies, peptide therapies, and other biologics—are...